Nivolumab

Therapeutic Nivolumab antibody from the original Opdivo® commercial drug

Showing all 8 results

Filter our product list:
API
Antigen / Target
Therapeutic Areas
Therapeutic Indications
Classes of molecule​s
Isotypes
Expiry Date
Filters Sort results
Product
Antigen
Molecular Class
Drug Brand
Product Concentration
Volume per Vial
Quantity per vial
Storage Temperature
Expiry Date
Price
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
200 µL
2 mg
-80°C
08/2018
269,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
200 µL
2 mg
-80°C
10/2018
269,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
200 µL
2 mg
-80°C
02/2018
269,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
200 µL
2 mg
-80°C
05/2019
269,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
200 µL
2 mg
-80°C
01/2019
269,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
200 µL
2 mg
-80°C
09/2020
269,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
200 µL
2 mg
-80°C
11/2020
269,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
200 µL
2 mg
-80°C
02/2021
269,00 
view product
Max: 10
Min: 1
Step: 1

Not looking for Nivolumab?

Search our therapeutic molecules product database

Evidentic Support
+49 (0) 30 959 99 8831

Let us know about your inquiry details and we’ll contact you shortly.